🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Flotufolastat F-18 Injection is a positron emission tomography (PET) imagin...
Status
Recruiting
Location
Chinese PLA General Hospital
Start Date
2025-06-07
Trial ID
NCT07149831
Treatments Being Tested
The purpose of this trial is to learn more about the effects of AAA602 and ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2026-06-29
Trial ID
NCT06881823
Treatments Being Tested
The goal of this clinical trial is to evaluate the diagnostic performance a...
Status
Recruiting
Location
Chinese PLA General Hospital
Start Date
2025-03-14
Trial ID
NCT07115277
Treatments Being Tested
The purpose of this study is to assess detection rate of flotufolastat F 18...
Status
Recruiting
Location
Massachusetts General Hospital
Start Date
2025-05-20
Trial ID
NCT06862856
Treatments Being Tested
This phase II trial evaluates how well flotufolastat F 18 positron emission...
Status
Recruiting
Location
UCLA / Jonsson Comprehensive Cancer Center
Start Date
2025-10-09
Trial ID
NCT07185165
This investigator-initiated, prospective study evaluates the diagnostic uti...
Status
Recruiting
Location
Mount Sinai Hospital / Icahn School of Medicine at Mount Sinai
Start Date
2026-02-10
Trial ID
NCT07285057
Treatments Being Tested
This clinical trial evaluates \[18F\]-rh PSMA positron emission tomography ...
Status
Active Not Recruiting
Location
City of Hope Medical Center
Start Date
2025-03-25
Trial ID
NCT06580015
This is a randomized, open-label, pilot study assessing the impact of a sho...
Status
Not Yet Recruiting
Location
Washington University School of Medicine
Start Date
2026-07-31
Trial ID
NCT07593079
A prospective, Phase 3, multi center, single-arm, imaging study investigati...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2020-05-04
Trial ID
NCT04186845
Treatments Being Tested